Introduction HIV-specific cytotoxic T-lymphocyte (CTL) responses are thought to play an important role in HIV-1 control [1] [2] [3] [4] . A hallmark of HIV-1 evolution, however, is the rapid appearance of mutations within CTL epitopes, leading to loss of CTL recognition and immune control [5] . HIV-2 differs from HIV-1 in that a substantial proportion of infected people maintain undetectable plasma viral loads for decades with no signs of immunodeficiency. Many others have viral loads 30-fold lower than HIV-1 at equivalent disease stages [6] [7] [8] [9] . We have previously demonstrated a strong correlation between the presence of high frequency HIV-2 Gagspecific CTLs and viral control [10] [11] [12] . As HIV-2 is able to generate resistance mutations akin to HIV-1 under antiretroviral pressure [13] , HIV-2 should also have the capacity to adapt to immune responses similar to HIV-1.
Establishing similarities and differences between HIV-1 and HIV-2 immune evasion strategies has the potential to enhance our understanding of HIV pathogenesis. HIV-1 p24 and HIV-2 p26 represent the two major CTL-targeted proteins in these viruses. Here, we provide the first comparison of selective pressure in HIV-1 p24 and HIV-2 p26 capsid sequences from a community cohort in GuineaBissau, along with HLA-associated viral polymorphisms in HIV-2,whichmayrepresentCTL-drivenadaptivechanges.
Methods
Study participants Antiretroviral therapy (ART)-naïve HIV-1 and HIV-2 mono-infected individuals from Cai o, Guinea-Bissau were recruited following written informed consent during serosurveys and case-control studies conducted in this rural community cohort over almost three decades [14] . CD4 and HIV-2 plasma viral load quantification [using an in-house reverse transcriptase (RT)-PCR assay] were performed as previously described [7, 12] . Viral loads were available in 75/ 86andCD4 þ countsin72/86of HIV-2-infectedindividuals. Median (range) viral load was 275 (<100-283 542) and CD4 þ T-cell count 547.5/mm 3 (100-1705). Thirty of seventy-five (40%) had a viral load of less than 100 copies/ml, whichisbroadlyreflectiveofthewidercohort [15] .HLAclass I genotyping on HIV-2-infected patients was performed during a previous study using sequencing [16, 17] . Ethical approval was provided by the joint MRC/Gambia Government Ethics Committee, Guinea-Bissau Ministry of Health and the Oxford Tropical Research Ethics Committee (OXTREC), United Kingdom.
Amplification and sequencing of HIV-1 and HIV-2 capsids Plasma samples from 55 CRF02_AG HIV-1-infected individuals were used to generate p24 capsid sequences using previously described methods [18] (Supplementary methods, http://links.lww.com/QAD/B217). Eightysix HIV-2 p26 capsid sequences were used in this study: 85 previously generated sequences (GenBank accession numbers GQ48544-GQ485550 and JX570541-JX570562) and 1 new sequence were generated using the same methodology [19] .
Sequence analysis and tests for codon selection Sites under positive and negative selection in HIV-1 (231 codons) and HIV-2 (230 codons) were identified by comparison of synonymous (dS, no amino acid change) and nonsynonymous (dN, amino acid change) substitution rates using three different methods in the Datamonkey web-server [20] : single-likelihood ancestor counting (SLAC), fixed-effects likelihood (FEL) and fast unbiased Bayesian approximation (FUBAR) [21, 22] (Supplementary methods, http://links.lww.com/QAD/ B217). A P-value cut-off of 0.05 (SLAC and FEL) and posterior probability of 0.95 (FUBAR) was used to define significant positive or negative selection at a codon.
Identification of HLA-associated HIV-2 viral polymorphisms HLA-associated HIV-2 viral polymorphisms were identified using a phylogenetically corrected logistic regression, used extensively for identifying HLA-associated HIV-1 viral polymorphisms [23] . This method corrects for phylogenic relatedness, HLA-linkage disequilibrium and codon covariation. Class I HLA types from 73 HIV-2-infected adults were available for this analysis. Separate statistical tests were constructed for each HLA-amino acid pair, limited to HLA alleles and amino acids that were observed in at least 5 and at most 68 individuals. To correct for multiple comparisons, we used a 20% false discovery rate (threshold P < 0.0008). Epitope predictions were made by scanning the candidate sequence for peptides of 8-11 amino acids, with each prediction made using the supplied HLA (2% prior probability distribution).
IFN-g enzyme-linked immunosorbent spot
Cryopreserved peripheral blood mononuclear cells (PBMCs) from HIV-2-infected patients were used in ex-vivo IFN-g enzyme-linked immunosorbent spot (ELISpot) assays as previously described [12] , to quantify responses to wild type and variant epitopes (Supplementary methods, http://links.lww.com/QAD/B217).
Results
Fewer adaptive changes are present in HIV-2 p26 compared with HIV-1 p24 Using three different algorithms [21, 22] , we evaluated selective pressure evident across the HIV-1 p24 and HIV-2 p26 capsids. In all analyses, there were more sites under positive selective pressure in HIV-1 p24 (6 vs. 2 in SLAC, Table 3 , http:// links.lww.com/QAD/B217). This may indicate constraints against evolution within these epitopes, thereby forcing evolutionary change in flanking regions. In contrast, all six HIV-1 p24 sites under positive selective pressure (identified by all three algorithms) lie within putative CTL epitopes restricted by HLA alleles common in Cai o (Supplementary Table 3 , http://links.lww.com/ QAD/B217), including the well described T242N mutation in the HLA-B Ã 57/B Ã 5801-restricted TW10 epitope (TSTLQEQIGW) [25, 26] .
Identification of a potential HLA-associated HIV-2 p26 polymorphism within a known HLA-B M 5801-restricted cytotoxic T-lymphocyte epitope We then identified five associations between HLA alleles and polymorphisms in HIV-2 p26 using a previously described statistical model [23] (Table 1) Robust T-cell responses to the HIV-2 TW10-like wildtype and mutant epitopes despite the presence of the E245D polymorphism in HLA B M 5801-positive individuals T242N escape within the HIV-1 TW10 epitope occurs early after infection, impacts HLA binding, leading to loss of CTL recognition and carries a fitness cost overcome by compensatory mutations [25, 26] . As robust CTL responses are found in HIV-2-infected individuals decades after infection [10, 12] , we examined IFN-g ELISpot responses to both wildtype HIV-2 (TSTVEE-QIQW) and E245D variant (TSTVDEQIQW) peptides. ELISpot responses to both peptide variants were observed in almost all individuals (Supplementary Table 4 , http:// links.lww.com/QAD/B217), including robust responses to the E245D mutant peptide. In all but one individual, the response was stronger against the peptide that matched the individual's autologous virus sequence, suggesting that the T-cell response in these individuals could adapt to overcome this particular CTL epitope polymorphism in HIV-2. In three donors where sufficient PBMCs were available to test, none had cross-reactive responses to HIV-1 TW10 (Supplementary  Table 4 , http://links.lww.com/QAD/B217).
Discussion
We report the first analysis of HLA-associated viral polymorphisms in HIV-2 p26, including a codon substitution within a known immunodominant HLA-B Ã 5801-restricted epitope. This may represent CTLdriven adaptation by HIV-2 and allows direct comparison with what is known about the equivalent HLA-B57/ B Ã 5801-restricted epitope in HIV-1. In contrast to HIV-1, wherever a mutation at position 3 of the epitope (T242N) occurs in 63-93% of HLA-B Ã 5801-positive individuals [25] , a mutation at position 5 (E245D) is found in 65% of HLA-B58 ST-positive patients. The HIV-1 TW10 epitope lies within a region essential for capsid formation [27] and residue 242 is thought to be critical to stabilizing the electrostatic charge along helix 6 [26] . A T242N mutation reduces this stabilizing effect [26] , consistent with viable virus with significantly reduced fitness. It is possible that for HIV-2, with much lower in-vivo viral titres than HIV-1, the fitness costs of such a mutation are too severe, leading to an alternative pathway of immune adaptation. Further functional studies are required to explore this hypothesis.
The E!D mutation found in HIV-2 replaces one hydrophilic, negatively charged, amino acid with another. In contrast to HIV-1 where T242N escape usually results in loss of immune control, robust CTL responses are generated against this HIV-2 mutant. The absence of E245D mutant responses in one participant (B58_8, Supplementary Table 4 , http://links.lww.com/QAD/ B217) suggests that these E245D variant responses do not simply represent cross-reactive CTLs. The presence of CTLs specific to both variants in most individuals may reflect low-level persistence of epitope variants in the viral population not detected by bulk PCR sequencing used in this study. These data also imply that this potential HIV-2 immune adaptation is at the level of T-cell receptor recognition of the peptide-MHC complex, as peptide processing and MHC-epitope binding of E245D variants are presumably still maintained.
We also describe the first comparison of selective pressure on HIV-1 and HIV-2 capsids, finding greater purifying selective pressure in HIV-2. We reported similar findings in HIV-2 env, where relative conservation of this highly The 10-mer TSTVEEQIQW has been previously identified as a B58_ST-restricted epitope via functional assays. The prediction algorithm used identifies the 9-mer STVDEQIQW as an optimal B58_ST-restricted epitope.
f NPVPVGNIY is a known BM35-restricted epitope.
variable gene is seen despite high magnitude autologous neutralizing antibody titres [28] . Although one explanation for the lower adaptive changes in HIV-2 is lower viral replication compared with HIV-1, previous studies have demonstrated that evolutionary rates are equivalent if not faster in advanced HIV-2 than in HIV-1 infection [29] . Furthermore, the emergence of ART-driven resistance mutations in HIV-2 shows that at least in the reverse transcriptase and protease genes, viral escape can readily occur [13] .
A key limitation of our study is the lack of longitudinal data following individual patients from acute HIV-2 infection to demonstrate CTL-driven escape, shown extensively in HIV-1 [1] [2] [3] [4] [5] . Although such a study would add considerable insight, the reducing incidence of HIV-2 infection in West Africa, on a background of vastly lower transmission rates than HIV-1, makes this challenging [14, 30] . Acute HIV-2 infection is difficult to identify, and therefore, rarely described. As an indirect way of investigating the issue of HIV-2 immune adaptation, we have, therefore, utilized a statistical model of evolution, well validated in HIV-1 cohorts [23, 31] . The significant proportion of HIV-2-infected individuals with low viral loads make generating sequence data challenging (approximately 50% success if viral load <100 copies/ml [19] ) and could lead to a biased dataset whenever compared with HIV-1. Nevertheless, our dataset represents the largest collection of sequence data generated from HIV-2-infected individuals with viral load less than 100 copies/ml to date [19] .
In conclusion, we provide the first evidence of adaptive changes in the HIV-2 capsid. Our data highlight fundamental differences in immune adaptation between HIV-1 and HIV-2, suggesting that HIV-2 evolution may be limited in this region. Further functional studies are required to characterize the polymorphisms identified in HIV-2, validate our findings and explore whether this characteristic explains why robust immune responses can persist in HIV-2-infected individuals for many years. This in turn may underpin the diverse outcomes seen in HIV-1 and HIV-2 infections, providing a crucial clue to the yet unsolved conundrum of the relatively attenuated nature of most HIV-2 infections.
